STAT News
-
As cyclospora illnesses surge to a record, Michigan officials eye lettuce as a possible cause
STAT News
—
-
Top Democrats question RFK Jr.’s health care advisory panel
STAT News
—
-
STAT+: Hospital chain HCA warns of lower profits as more patients go uninsured
STAT News
—
-
STAT+: Anthropic’s Claude Science is coming for Kendall Square
STAT News
—
-
Majority of new Ebola cases are ‘from unknown chains of transmission,’ WHO official says
STAT News
—
-
STAT+: Akero team, backed by Fairmount, launches new immunology company
STAT News
—
-
The risk of refusing a newborn’s vitamin K shot
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
STAT News
—
-
STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows
STAT News
—
-
FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist
STAT News
—
-
Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctor
STAT News
—
-
STAT+: 10 charts that explain America’s hidden alcohol epidemic
STAT News
—
-
12 ideas for tackling the U.S. alcohol epidemic
STAT News
—
-
STAT+: Drug metabolism AI competition results show that bigger may not always be better
STAT News
—
-
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
STAT News
—
-
STAT+: Dementia study replicates promising outcomes following risk-reduction strategies
STAT News
—
-
STAT+: UnitedHealth’s questionable review, and more MA stars lawsuits
STAT News
—
-
Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahoma
STAT News
—
-
STAT+: All eyes on data on Biogen’s tau therapy
STAT News
—
-
STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
STAT News
—
-
Caregivers brace for pay cuts, and maybe homelessness
STAT News
—
-
Opinion: The shortage of forensic pathologists is hurting justice, public health, and families
STAT News
—
-
Opinion: Is there a doctor on board? Yes, and airlines depend on it
STAT News
—
-
STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
STAT News
—
-
As states absorb Medicaid funding cuts, family caregivers face financial ruin
STAT News
—
-
STAT+: HHS presses ahead with effort to curb antidepressant use
STAT News
—
-
STAT+: Tau in the spotlight at Alzheimer’s conference
STAT News
—
-
Nominee for key federal health role has a history of questioning vaccines
STAT News
—
-
STAT+: Roche ends Huntington’s gene-silencing programs
STAT News
—
-
STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
STAT News
—
-
FDA quietly pushes back deadline on electric shock ban
STAT News
—
-
Opinion: The primary care crisis paradox
STAT News
—
-
New York boys club has a time-tested recipe to protect members’ mental health
STAT News
—
-
STAT+: How a Boston doctor built a following as a ‘loud and unafraid’ voice in the Trump era
STAT News
—
-
Whistleblower takes on health insurance and FDA commissioner candidates
STAT News
—
-
Outbreak of diarrhea-causing parasite grows to more than 1,000 cases
STAT News
—
-
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
STAT News
—
-
STAT+: FDA finalists under review
STAT News
—
-
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT News
—
-
STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more
STAT News
—
-
STAT+: OpenEvidence backs study that finds it beats LLMs
STAT News
—
-
Who’s going to run the FDA?
STAT News
—
-
STAT+: 931 days. The drug approval scandal hiding in plain sight
STAT News
—
-
STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug
STAT News
—
-
Opinion: Your grandparents are using cannabis. Doctors can help them do it safely
STAT News
—
-
Opinion: Who benefits from classifying obesity as a disease?
STAT News
—
-
STAT+: The quest to save Grace — and clear the way for rare disease patients everywhere
STAT News
—
-
What happens on ‘MAHA Monday’?
STAT News
—
-
STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccines
STAT News
—
-
STAT+: White House reviewing top contenders to lead FDA
STAT News
—
-
STAT+: Brigham and Women’s Hospital nurses walk out, beginning largest nurses strike in Massachusetts history
STAT News
—
-
STAT+: In private meeting, Trump officials push to onshore generic drugmaking
STAT News
—
-
Bryan Johnson’s chronic disease is notoriously difficult to diagnose
STAT News
—
-
Affordable Care Act insurers want more premium increases as enrollment sags
STAT News
—
-
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
STAT News
—
-
STAT+: Europe will accelerate its review of RevMed’s drug
STAT News
—
-
STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
STAT News
—
-
Another big premium hike on the horizon
STAT News
—
-
Opinion: STAT+: What’s the right role for AI in dementia care?
STAT News
—
-
Opinion: The AI licensure debate is missing the point of licensure
STAT News
—
-
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
STAT News
—
-
STAT+: Trump administration pursues more durable changes to science policy after setbacks in court
STAT News
—
-
STAT+: FDA approves Vera Therapeutics kidney disease treatment
STAT News
—
-
STAT+: The crumbling employer-based health insurance system
STAT News
—
-
STAT+: Compass says depression drug has long-lasting benefits
STAT News
—
-
STAT+: America’s employer health insurance is decaying
STAT News
—
-
STAT+: ‘Secret shopper’ study probes GLP-1 telehealth sites
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
STAT News
—
-
Ebola outbreak exposes a fractured outbreak response system
STAT News
—
-
Opinion: Medicine thinks Gen Z is too soft. It’s wrong
STAT News
—
-
STAT+: For a Georgia entrepreneur, health coverage has never been affordable
STAT News
—
-
STAT+: America’s small businesses are giving up on health insurance
STAT News
—
-
STAT+: This whistleblower took on a health insurance giant and a political machine. She’s not stopping there
STAT News
—
-
Opinion: What if this Ebola outbreak can’t be stopped?
STAT News
—
-
5 takeaways from STAT’s series on the soaring cost of health insurance
STAT News
—
-
STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms
STAT News
—
-
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows
STAT News
—
-
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight
STAT News
—
-
STAT+: Four major biotech updates to catch up on
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
STAT News
—
-
The race for an Ebola therapy begins
STAT News
—
-
Opinion: The smart way to regulate the peptide boom
STAT News
—
-
Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fix
STAT News
—
-
STAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diverse
STAT News
—
-
STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
STAT News
—
-
What does content creation do to mental health?
STAT News
—
-
STAT+: Medicare takes another swing at 340B cuts to hospitals
STAT News
—
-
STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals
STAT News
—
-
STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratings
STAT News
—
-
STAT+: Up and down the ladder: The latest comings and goings
STAT News
—
-
STAT+: What does DeGette’s loss mean for pharma?
STAT News
—
-
STAT+: Roche drug sets new standard for KRAS-driven lung cancer
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
STAT News
—
-
STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
STAT News
—
-
STAT+: More frequent, more intense, and longer heat waves pose health risks for Americans
STAT News
—
-
STAT+: Halfway into the year, biotech is booming
STAT News
—
-
Opinion: Teens are turning to chatbots for mental health help. We need rules to keep them safe
STAT News
—
-
Opinion: CDC leadership continues to try manufacture a scientific debate on vaccines where none exists
STAT News
—
-
STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
STAT News
—
-
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
STAT News
—
-
The new presidential fitness test is a positive step, not the solution, experts say
STAT News
—
-
STAT+: A ‘historic’ FDA clearance raises the question: Is LLM the interface? Or the decision-maker?
STAT News
—
-
Statins and blood pressure drugs changing health risks of obesity, study suggests
STAT News
—
-
STAT+: The moment Anthropic convinced me it’s serious about science
STAT News
—
-
STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?
STAT News
—
-
STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and more
STAT News
—
-
STAT+: More signs that GLP-1s may help with peripheral artery disease
STAT News
—
-
FDA says Zyn can market its pouches as safer than cigarettes
STAT News
—
-
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
STAT News
—
-
STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenes
STAT News
—
-
STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watch
STAT News
—
-
Opinion: Maryland Gov. Wes Moore: How to improve young men’s mental health
STAT News
—
-
Opinion: What Ebola and Marburg are teaching us about the next pandemic
STAT News
—
-
STAT+: AI company Anthropic announces it will begin developing drugs of its own
STAT News
—
-
Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congress
STAT News
—
-
STAT+: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry
STAT News
—
-
Marburg outbreak is reported in Uganda, threatening to complicate Ebola response in region
STAT News
—
-
STAT+: All of Us tests a new approach to collect real-world data for research
STAT News
—
-
STAT+: Investors double down on Bain-backed startup
STAT News
—
-
STAT+: FDA digital leader hints at coming AI policy updates
STAT News
—
-
STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and more
STAT News
—
-
Half of states sue over Medicaid work requirements
STAT News
—
-
STAT+: How the Trump administration derailed alcohol addiction research and prevention
STAT News
—
-
Opinion: Florida is the first state to require EKGs for high school athletes. It’s a mistake
STAT News
—
-
STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk
STAT News
—
-
Opinion: Short-sighted new student loan caps elevate chiropractic care over critical health care professions
STAT News
—
-
STAT+: Abivax seeks to ease safety concerns with new data, boosting shares
STAT News
—
-
STAT+: FDA’s top gene therapy regulator is leaving his role
STAT News
—
-
STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney general
STAT News
—
-
STAT+: 26 states sue to block Medicaid work requirements
STAT News
—
-
5 takeaways from STAT’s investigation into microhospital operator Nutex Health
STAT News
—
-
STAT+: Unredacted comments from California hospital lawsuits show stunning admissions and a ‘forced’ McKinsey collaboration
STAT News
—
-
STAT+: Longevity, wellness physicians named to panel advising FDA on peptides
STAT News
—
-
STAT+: Talawar bets bispecific approach can shake up eczema market
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more
STAT News
—
-
What’s next for 988 LGBTQ+ services?
STAT News
—
-
STAT+: The ERs that can turn patients away — and are reaping millions
STAT News
—
-
Opinion: Banning gender-affirming care doesn’t protect children — it makes it harder to help them
STAT News
—
-
Opinion: STAT+: The U.S.-China biotech crackdown may hurt the scientists America needs the most
STAT News
—
-
STAT+: Sword Health contracted to provide AI-supported physical therapy for an entire country
STAT News
—
-
STAT+: Investor Clive Meanwell on designing biotechs for population health, and AI’s role as a catalyst
STAT News
—
-
STAT+: Moderna co-founder Kenneth Chien on the future of mRNA — and Moderna
STAT News
—
-
STAT+: AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
STAT News
—
-
Opinion: Supreme Court ruling on Roundup points to a confusing difference between the law and science
STAT News
—
-
BIO 2026: AI, federal policy impacts, and general vibes
STAT News
—
-
STAT+: Up and down the ladder: The latest comings and goings
STAT News
—
-
988’s LGBTQ+ hotline to relaunch this year. But the group that helped start it might be excluded
STAT News
—
-
STAT+: Embryo editing advances reignite ethical debates
STAT News
—
-
STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more
STAT News
—
-
STAT+: European antitrust regulators probe Sanofi for allegedly disparaging a rival flu vaccine
STAT News
—
-
Supreme Court rules in weedkiller cancer case
STAT News
—
-
Jails are the frontline in fielding dangerous new type of drug withdrawal
STAT News
—
-
Opinion: ‘The Hot Zone’ led me to work with Ebola patients. Now I have mixed feelings about the book
STAT News
—
-
Opinion: Joseph Fraumeni Jr., pioneering cancer genetics researcher, devoted his life to families like mine
STAT News
—
-
What is pulmonary hypertension and why would a new GLP-1 help?
STAT News
—
-
New ACIP charter broadens criteria for members, calls for review of alternatives to vaccines
STAT News
—
-
STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better
STAT News
—
-
The mysterious case of Eli Lilly’s obesity drug
STAT News
—
-
STAT+: Cassidy proposes bill to rein in 340B drug discount program
STAT News
—
-
Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller
STAT News
—
-
STAT+: Proposed CDC science office could tighten political control at agency
STAT News
—
-
STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug
STAT News
—
-
STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns
STAT News
—